You might want to know how prostate cancer will affect you, and whether you are likely to survive or die from prostate cancer. But not all men will want to know this.

No one can tell you exactly what will happen to you. But your doctor or nurse might be able to give you an idea based on the outcomes of other men with similar cancer and treatments to you. This is sometimes called your outlook, prognosis, or life expectancy.

What can affect my outlook?

No one can tell you exactly what will happen. How prostate cancer affects you will depend on many things.

  • Your stage – Whether your cancer is localised, locally advanced, or advanced.
  • Your Gleason score or grade group – The higher your Gleason score, the more aggressive the cancer, and the more likely it is to spread.
  • Your treatment options – You may be able to have treatment aimed at getting rid of the cancer. Or you may be able to have treatment to keep the cancer under control. Read more about choosing your treatment.
  • Your health – If you have other health problems, you may have fewer treatment options. And you may be more likely to die from another condition, such as heart disease.
  • Your PSA level – After you’ve been diagnosed, PSA tests are a good way of monitoring your prostate cancer and seeing how you’re responding to treatment.
  • How successful your treatment is – Your treatment may be successful at getting rid of your cancer or keeping it under control. But for some men, treatment may not work as well as expected.

Outlook for men with localised prostate cancer

Most localised prostate cancer is slow-growing and may not need treatment or shorten a man’s life. For many men who have treatment for localised prostate cancer, the treatment will get rid of the cancer. For others, treatment may be less successful and the cancer may come back. If this happens, you might need further treatment.

Outlook for locally advanced prostate cancer

Many men with locally advanced prostate cancer have treatment that aims to get rid of their cancer. For some men, this treatment can be very successful and they may live for many years without their cancer coming back or causing them any problems. For others, treatment may be less successful and the cancer may come back. If this happens, you might need further treatment. Read more about the risk of your cancer coming back.

Some men with locally advanced prostate cancer will have treatment that aims to help keep their cancer under control rather than get rid of it completely. For example, if you have hormone therapy on its own, it can help to keep the cancer under control, usually for several years. And there are other treatments available if your hormone therapy stops working.

Outlook for men with advanced prostate cancer

While it isn’t possible to cure advanced prostate cancer, treatments can help keep it under control, often for several years. Treatments will also help manage any symptoms, such as pain.

Some men may not respond well to one treatment, but may respond better to another. And when your first treatment stops working, there are other treatments available to help keep the cancer under control for longer.

Survival statistics

For more information about the outlook for men with prostate cancer, visit the Cancer Research UK website. The figures they provide are a general guide and they cannot tell you exactly what will happen to you. Speak to your doctor or nurse about your own situation.

References

Updated: July 2019 | Due for review: September 2021

  • List of references  

    • Cancer Research UK. Prostate cancer survival by stage at diagnosis [Internet]. Cancer Research UK. 2016 [cited 2019 Mar 29]. Available from: www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/survival
    • Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. N Engl J Med. 2016 Sep 14;
    • James ND, Spears MR, Clarke NW, Dearnaley DP, De Bono JS, Gale J, et al. Survival with Newly Diagnosed Metastatic Prostate Cancer in the “Docetaxel Era”: Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019). Eur Urol. 2015 Jun;67(6):1028–38.
    • National Institute for Health and Care Excellence. Prostate Cancer: diagnosis and treatment. Full guideline 175. 2014.
  • List of reviewers  

    • Ann French, Lead Urology Oncology CNS, Southend University Hospital
    • Ann Henry, Associate Professor in Clinical Oncology, Leeds Teaching Hospitals NHS Trust
    • Anup Patel, Consultant Urologist, Spire London East Hospital
    • Bev Baxter, Urology and Oncology Clinical Nurse Specialist, Royal Derby Hospital, University Hospitals of Derby and Burton NHS Foundation Trust.
    • Christopher Eden, Consultant Urologist, The Royal Surrey County Hospital Foundation Trust
    • Jane Booker, Clinical Nurse Specialist, Christie Hospital NHS Foundation Trust
    • Lisa Pickering, Consultant Medical Oncologist, St George's University Hospitals Foundation Trust and Royal Marsden NHS Trust
    • Maggie Bingle, Prostate Cancer Clinical Nurse Specialist, East Suffolk and North Essex NHS Foundation Trust
    • Natalie Mart, Urology Oncology Clinical Nurse Specialist, Royal Derby Hospital, University Hospitals of Derby and Burton NHS Foundation Trust.
    • Nikola Hawkins, Consultant AHP and Cancer Rehab Lead, Gloucestershire Care Services NHS Trust
    • Peter Hoskin, Consultant Clinical Oncologist, Mount Vernon Cancer Centre, East and North Herts NHS Trust
    • Philip Reynolds, Consultant Radiographer in Prostate Radiotherapy, Clatterbridge Cancer Centre NHS Foundation Trust
    • Sidath Liyanage, Consultant Radiologist, Southend University Hospital
    • Tracey Ellis, Macmillan Consultant Radiographer, Lancashire Teaching Hospitals NHS Foundation Trust
    • Vanessa Basketter, Urology Lead Nurse, University Hospital Southampton
    • Our Specialist Nurses
    • Our Volunteers.